GSK Stock Guidance | NYSE:GSK

Comments

GSK PLC Stock Guidance

GSKNYSE

Trade with Public

$59.01

-1.22-2.03%

At close: Feb 6, 4:00 PM EST

$59.51

-0.72-1.20%

Pre-Market: 4:51 AM EST

Earnings: Q4 2025 Earnings were released on Wed Feb 4th, before the market open

Conference Call: The most recent conference call started at 6:00 AM, 6 days ago

Click to view the webcast

Overview News Earnings Options

Guidance

Dividends Analyst Ratings Short Interest Government Trades Stock Report

GSK Stock Guidance | NYSE:GSK | Benzinga

GSK issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

FAQ

What is the most recent guidance for GSK (GSK)?

The most recent guidance for GSK (GSK) was reported on February 4, 2026 for the full year 2026. The company provided earnings per share guidance in the range of $4.90 to $5.00, compared to the estimated EPS of $4.87. Additionally, GSK forecasted revenue between $44.75B and $45.62B for the quarter.

People Also Watch

Axsome Therapeutics Inc

NASDAQ:AXSM

$183.22

Jazz Pharmaceuticals PLC

NASDAQ:JAZZ

$165.10

0.06%